ATE536101T1 - Behandlung heilmittelresistenter proliferativer erkrankungen - Google Patents

Behandlung heilmittelresistenter proliferativer erkrankungen

Info

Publication number
ATE536101T1
ATE536101T1 AT06717284T AT06717284T ATE536101T1 AT E536101 T1 ATE536101 T1 AT E536101T1 AT 06717284 T AT06717284 T AT 06717284T AT 06717284 T AT06717284 T AT 06717284T AT E536101 T1 ATE536101 T1 AT E536101T1
Authority
AT
Austria
Prior art keywords
treatment
drug
proliferative diseases
resistant
resistant proliferative
Prior art date
Application number
AT06717284T
Other languages
English (en)
Inventor
M V Ramana Reddy
E Premkumar Reddy
Stephen Cosenza
Stacey Baker
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Application granted granted Critical
Publication of ATE536101T1 publication Critical patent/ATE536101T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT06717284T 2005-01-05 2006-01-04 Behandlung heilmittelresistenter proliferativer erkrankungen ATE536101T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64137805P 2005-01-05 2005-01-05
PCT/US2006/000059 WO2006074149A2 (en) 2005-01-05 2006-01-04 Treatment of drug-resistant proliferative disorders

Publications (1)

Publication Number Publication Date
ATE536101T1 true ATE536101T1 (de) 2011-12-15

Family

ID=36648100

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06717284T ATE536101T1 (de) 2005-01-05 2006-01-04 Behandlung heilmittelresistenter proliferativer erkrankungen

Country Status (9)

Country Link
US (1) US20090306207A1 (de)
EP (1) EP1841420B1 (de)
JP (1) JP5156389B2 (de)
KR (2) KR20070094956A (de)
AT (1) ATE536101T1 (de)
AU (1) AU2006204103B2 (de)
CA (1) CA2593523C (de)
IL (1) IL184292A (de)
WO (1) WO2006074149A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007065124A2 (en) * 2005-12-01 2007-06-07 Bristol-Myers Squibb Company Methods of identifying and treating individuals exhibiting complex karyotypes
US8962614B2 (en) 2008-04-17 2015-02-24 The Johns Hopkins University ON01910.Na enhances chemotherapeutic agent activity in drug-resistant tumors
KR101992929B1 (ko) 2012-09-20 2019-06-25 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 치환된 알킬 디아릴 유도체, 제조방법 및 용도
US10383831B2 (en) 2015-08-03 2019-08-20 Temple University—Of the Commonwealth System of Higher Education 2,4,6-trialkoxystryl aryl sulfones, sulfonamides and carboxamides, and methods of preparation and use
CN111926086B (zh) * 2020-08-21 2022-05-31 云南农业大学 一种影响鸡体斜长的分子标记及其应用
JP2024531238A (ja) * 2021-08-12 2024-08-29 オンコノヴァ セラピューティクス， インコーポレイテッド がんを処置するための方法および組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY119291A (en) * 1996-07-25 2005-04-30 Alloystream Holdings Proprietary Ltd Metal reduction and melting process
AU741042B2 (en) * 1997-10-03 2001-11-22 Temple University - Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents
US6548553B2 (en) 1997-10-03 2003-04-15 Temple University-Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents
US6762207B1 (en) * 1999-04-02 2004-07-13 Temple University - Of The Commonwealth System Of Higher Education (E)-styryl sulfone anticancer agents
EP1173160B1 (de) * 1999-04-02 2005-06-22 Temple University of the Commonwealth System of Higher Education (e)-styrylsulfone als krebsbestreitende mittel
US6767926B1 (en) * 1999-10-12 2004-07-27 Temple University - Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
US6243322B1 (en) * 1999-11-05 2001-06-05 Wavemakers Research, Inc. Method for estimating the distance of an acoustic signal
US6541475B2 (en) * 2000-04-14 2003-04-01 Temple University - Of The Commonwealth System Of Higher Education α, β-unsaturated sulfones for treating proliferative disorders
US6486210B2 (en) * 2000-04-14 2002-11-26 Temple University—Of the Commonwealth System of Higher Education Substituted styryl benzylsulfones for treating proliferative disorders
AU2002305942B2 (en) * 2001-02-28 2006-10-26 Onconova Therapeutics, Inc. Method for protecting cells and tissues from ionizing radiation toxicity with Alpha, Beta unsaturated aryl sulfones
WO2003072062A2 (en) * 2002-02-28 2003-09-04 Temple University-Of The Commonwealth System Of Higher Education Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
EP1534284B1 (de) * 2002-02-28 2011-07-27 Temple University - Of The Commonwealth System of Higher Education Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen
JP5196787B2 (ja) * 2003-11-14 2013-05-15 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 増殖性疾患を治療するためのα，β−不飽和スルホキシド
KR101274524B1 (ko) * 2004-03-16 2013-06-19 온코노바 테라퓨틱스, 인코포레이티드 증식성 질병 치료용 치환 페녹시- 및 페닐티오- 유도체

Also Published As

Publication number Publication date
IL184292A (en) 2012-10-31
IL184292A0 (en) 2007-10-31
JP5156389B2 (ja) 2013-03-06
JP2008526852A (ja) 2008-07-24
EP1841420A2 (de) 2007-10-10
KR101427105B1 (ko) 2014-08-07
US20090306207A1 (en) 2009-12-10
AU2006204103B2 (en) 2011-11-24
EP1841420B1 (de) 2011-12-07
KR20130091796A (ko) 2013-08-19
CA2593523A1 (en) 2006-07-13
KR20070094956A (ko) 2007-09-27
AU2006204103A1 (en) 2006-07-13
WO2006074149A2 (en) 2006-07-13
WO2006074149A3 (en) 2007-11-15
CA2593523C (en) 2014-04-08
EP1841420A4 (de) 2009-12-09

Similar Documents

Publication Publication Date Title
ATE530524T1 (de) Substituierte sulfonamid-derivate
EA200900983A1 (ru) Соединения и композиции в качестве ингибиторов киназы
MX2022004937A (es) Inhibidores de las cinasas raf.
DOP2009000141A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteína quinasa
CR10072A (es) Derivados de pirimidinil-aril-urea que son inhibidores de fgf
MX383856B (es) Compuestos y composiciones para inhibir la actividad de shp2.
DK1625126T3 (da) Imidazo- og thiazolopyridiner som JAK3-kinaseinhibitorer
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
NO20084652L (no) Deazapuriner anvendelige som inhibitorer av januskinaser
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
UA87153C2 (ru) Энантиомерно чистые аминогетероарильные соединения как ингибиторы протеинкиназы
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200970156A1 (ru) Пиридизиноновые производные
EA200801362A1 (ru) Пиримидинил бензотиофеновые соединения
EA201100447A1 (ru) Органические соединения
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
EA200700489A1 (ru) Новые бензоконденсированные гетероарилсульфамидные производные, полезные в качестве противоконвульсивных средств
EA201500403A1 (ru) Соединения, активирующие теломеразу, и способы их применения
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
MA32505B1 (fr) 5-alcynyl-pyrimidines
CO6630193A2 (es) Inhibidores de la actividad de la proteína tirosina quinasa seleccionada
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
ATE502935T1 (de) C-met-proteinkinasehemmer